Brendan Lally-McGurl

Brendan’s recent representative experience includes:

• Qualtrics in its definitive agreement to be acquired by Silver Lake, in partnership with CPP Investments, for approximately $12.5 billion
• VBL Therapeutics in its definitive merger agreement with Notable Labs
• Concert Pharmaceuticals in their definitive agreement to be acquired by Sun Pharmaceutical for $576 million and contingent value rights
• Checkmate Pharmaceuticals in its acquisition by Regeneron Pharmaceuticals